Viscosupplementation is a recognized therapeutic approach for knee osteoarthritis treatment. It involves injecting hyaluronic acid directly into the joint to restore the viscoelastic properties of synovial fluid altered by osteoarthritis. This educational guide explains what viscosupplementation is, how it works, which patients benefit most, and what you can realistically expect.
What is Viscosupplementation?
Synovial fluid is naturally rich in hyaluronic acid, a molecule that gives it its lubricating and shock-absorbing properties. In osteoarthritis, the concentration and quality of this hyaluronic acid are reduced — the fluid becomes more watery, less viscous, and loses its protective capacities. Cartilage surfaces become increasingly exposed to mechanical stress.
Viscosupplementation involves injecting exogenous hyaluronic acid into the joint space to compensate for this deficit. These preparations are derived either from rooster combs (avian-origin hyaluronic acid) or through bacterial fermentation (biosynthetic hyaluronic acid) for non-animal formulations.
Viscosupplementation is not strictly a regenerative therapy — it does not rebuild cartilage. Its primary objective is to reduce pain and improve joint function by restoring a more favorable intra-articular environment.
Mechanism of Action
Injected hyaluronic acid exerts its effects through several complementary mechanisms:
- Mechanical lubrication — Partial restoration of synovial fluid viscosity, reducing friction between joint surfaces during slow movements.
- Shock absorption — Elastic properties that protect cartilage during dynamic loading (walking, stairs, light sports activities).
- Biological effects — Hyaluronic acid interacts with cellular receptors (notably CD44) on synoviocytes and chondrocytes, potentially modulating the intra-articular inflammatory response and reducing certain pro-inflammatory cytokines.
- Possible chondroprotective effect — Some studies suggest hyaluronic acid may have a favorable effect on chondrocyte metabolism, though the magnitude of this effect remains debated in the scientific literature.
These mechanisms explain why relief develops gradually over 4 to 12 weeks after injection, rather than immediately like a local anesthetic or rapidly like cortisone.
Main Indications
Viscosupplementation is primarily indicated in the following situations:
Knee Osteoarthritis (Gonarthrosis)
- Kellgren-Lawrence grades 2-3 — Moderate to moderately severe osteoarthritis with visible joint space narrowing, but joint space still present. This is the primary and best-documented indication.
- Failure of conservative treatments — Physiotherapy, weight management, oral analgesics and therapeutic exercises insufficient to control symptoms.
- Alternative or complement to cortisone — For patients wishing to avoid repeated corticosteroid injections, or whose symptoms persist between cortisone cycles.
- Contraindication to NSAIDs — Patients with peptic ulcer history, mild-to-moderate renal insufficiency, or cardiovascular risk limiting oral anti-inflammatory use.
Limitations of the Indication
- Grade 4 (severe) osteoarthritis — In cases of advanced joint destruction with near-total absence of joint space, results are generally disappointing. Total knee replacement should be considered.
- Significant joint effusion — A large effusion should be treated before or simultaneously with viscosupplementation to optimize results.
To learn more about the injection services offered, visit our services page.
The Procedure: Step by Step
Viscosupplementation is performed in the medical office and requires neither general anesthesia nor hospitalization:
- Medical consultation — Clinical assessment, review of X-rays (and/or MRI if available), confirmation of indication, and discussion of realistic expectations.
- Site preparation — Thorough disinfection of the knee skin. A local skin anesthetic may be used to optimize comfort.
- Aspiration of effusion (if present) — If fluid is present in the joint, it is aspirated before injection to maximize treatment effectiveness.
- Ultrasound-guided injection — The physician uses real-time ultrasound to visualize the joint and ensure the product is injected precisely into the intra-articular space. This precision improves efficacy and reduces risks.
- Post-injection care — Relative rest recommended for 24 to 48 hours. Avoid sustained effort and intense sports within 48 to 72 hours of injection.
Depending on the product used, the protocol involves either a single injection (high-concentration products such as Durolane or Monovisc) or 3 weekly injections (products such as Synvisc). Both approaches have demonstrated comparable efficacy in clinical studies.
Common Viscosupplementation Products
Several hyaluronic acid preparations are available in Canada. They differ in molecular weight, origin (avian or biosynthetic), concentration, and injection protocol:
| Product | Origin | Protocol | Characteristics |
|---|---|---|---|
| Synvisc / Synvisc-One | Avian (rooster comb) | 3 injections (weekly) or 1 injection (Synvisc-One) | High molecular weight; extensive clinical experience |
| Durolane | Biosynthetic (bacterial) | Single injection | NASHA technology; suitable for avian allergies |
| Monovisc | Biosynthetic | Single injection | High concentration; simplified protocol |
Product selection depends on potential allergy to avian proteins, patient preference (number of visits), product availability, and the physician's clinical judgment. Available data do not show clear superiority of one product over another in terms of overall efficacy.
Expected Results and Duration of Effect
The typical response profile to viscosupplementation is characterized by progressive improvement:
- First weeks (0-4 weeks) — Little or no noticeable improvement. Some patients report a brief transient increase in pain within 24 to 72 hours of injection — an expected and generally short-lived reaction.
- Progressive improvement (4-8 weeks) — The majority of responders begin to notice reduced pain and improved mobility.
- Optimal benefit (8-12 weeks) — Maximum effect is typically reached 2 to 3 months after the last injection.
- Duration of effect — Clinical studies document a benefit duration of 6 to 12 months for most responders, with some patients reporting benefit up to 18 months.
- Repeatability — Treatment can be repeated, generally at 6 to 12-month intervals, based on individual response and clinical judgment.
It is important to note that not all patients respond to viscosupplementation. Factors associated with better response include less advanced osteoarthritis (grades 2-3), moderate BMI, and the absence of significant effusion at the time of injection.
Side Effects and Contraindications
Viscosupplementation is generally well tolerated. The most common adverse effects are local and transient:
- Post-injection pain and swelling — Most common, affecting 10 to 15% of patients. Typically lasts 1 to 3 days and responds well to rest and ice.
- Pseudo-septic reaction — A more intense inflammatory reaction (redness, warmth, marked swelling), rare (less than 2%), occurring primarily with avian-origin products. Must be distinguished from actual infection by joint aspiration if the reaction is severe.
- Bruising at injection site — Temporary and benign.
- Joint infection (septic arthritis) — A serious but exceptionally rare complication with rigorous aseptic technique.
Main contraindications include:
- Known allergy to hyaluronic acid or avian proteins — For avian-origin products; biosynthetic formulations can be used in these patients.
- Active knee infection or periarticular skin infection
- Severe grade 4 osteoarthritis — Very limited efficacy
- Pregnancy — As a precaution; insufficient data available
- Anticoagulation — Discuss with physician; adjustment may be necessary
Viscosupplementation vs. PRP vs. Cortisone: Comparison
Here is an educational comparison of the three main injection options in sports medicine for knee osteoarthritis:
| Treatment | Mechanism | Main Indications | Onset of Action | Duration of Effect |
|---|---|---|---|---|
| Viscosupplementation | Joint lubrication via hyaluronic acid — restores synovial viscoelasticity | Knee osteoarthritis grades 2-3, failure of conservative treatments | 4 to 12 weeks | 6 to 12 months |
| PRP | Biological growth factors — stimulates tissue regeneration | Chronic tendinopathies, osteoarthritis, partial tears | 2 to 6 weeks | 6 to 18 months (variable) |
| Cortisone | Potent synthetic anti-inflammatory | Inflammatory flare, bursitis, rapid pain relief | 1 to 7 days | 1 to 6 months |
The choice between these approaches depends on the patient's clinical profile, osteoarthritis stage, previously attempted treatments, and patient preferences. To learn more, read our articles on cortisone injection and PRP injection.
FAQ — Frequently Asked Questions About Knee Viscosupplementation
Is viscosupplementation covered by insurance in Quebec?
No. Viscosupplementation is not covered by the RAMQ (Quebec public health insurance). Some private insurance plans may reimburse part or all of the cost — check with your insurer. For pricing details, visit our pricing page.
How many injections are needed and how often?
Depending on the product used, the protocol involves either a single injection (Durolane, Monovisc, Synvisc-One) or 3 weekly injections (classic Synvisc). Treatment can be repeated, generally every 6 to 12 months, based on clinical response and medical judgment.
Can viscosupplementation avoid or delay a knee replacement?
For some patients with well-selected moderate osteoarthritis, viscosupplementation may contribute to improving quality of life and delaying the need for surgery. It does not cure osteoarthritis or regenerate cartilage. The decision to proceed with total knee replacement is based on a comprehensive assessment and belongs to the patient in consultation with their medical team.
Is viscosupplementation effective for joints other than the knee?
The knee is the joint with the most solid and abundant evidence. Viscosupplementation can also be used for other joints (hip, shoulder, ankle), but with less robust evidence. Your physician will evaluate the indication based on your specific situation.
How can I book an evaluation appointment?
You can book a consultation directly online through our Pomelo booking system. Dr. Labrecque-Sauvé will perform a thorough clinical evaluation to determine whether viscosupplementation is indicated in your case and will discuss available options with you.